SymbolAUPH
NameAURINIA PHARMACEUTICALS INC.
SectorUNDEFINED
RegionUNDEFINED
IndustryPharmaceutical Preparations
Address#140, 14315 - 118 AVENUE, EDMONTON, A0 T5L 4S6
Telephone250-744-2487
Fax
Email
Website
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001600620
Description

None

2026-07-06 12:05

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis

Read more
2026-07-06 12:00

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis

Read more
2026-06-08 20:14

Director Johnson Craig A 🟢 acquired 23.9K shares (1 derivative) of Aurinia Pharmaceuticals Inc. (AUPH) at $15.67 Transaction Date: Jun 04, 2026 | Filing ID: 000002

Read more
2026-06-08 20:12

Director Goetz Kathleen 🟢 acquired 23.9K shares (1 derivative) of Aurinia Pharmaceuticals Inc. (AUPH) at $15.67 Transaction Date: Jun 04, 2026 | Filing ID: 000002

Read more
2026-06-08 20:10

Director Nova Tina Susan 🟢 acquired 23.9K shares (1 derivative) of Aurinia Pharmaceuticals Inc. (AUPH) at $15.67 Transaction Date: Jun 04, 2026 | Filing ID: 000002

Read more
2026-06-08 20:08

Director Bailey Jeffrey Allen 🟢 acquired 23.9K shares (1 derivative) of Aurinia Pharmaceuticals Inc. (AUPH) at $15.67 Transaction Date: Jun 04, 2026 | Filing ID: 000002

Read more
2026-06-05 20:27

📋 GREGORY KEENAN (Ex-Affiliate) plans to sell 10K shares of AURINIA PHARMACEUTICALS INC. (at $16.52 each, total $158K) Filed: Jun 05, 2026 | ID: 005702

Read more
2026-06-04 20:18

(99% Neutral) AURINIA PHARMACEUTICALS INC. (AUPH) Files Form 8-K

Read more
2026-06-04 20:12

📋 GREGORY KEENAN (Ex-Affiliate) plans to sell 25K shares of AURINIA PHARMACEUTICALS INC. (at $16.34 each, total $408K) Filed: Jun 04, 2026 | ID: 005622

Read more
2026-06-04 19:45

New Form SCHEDULE 13D/A - Aurinia Pharmaceuticals Inc. <b>Filed:</b> 2026-06-04 <b>AccNo:</b> 0001214659-26-007175 <b>Size:</b> 28 KB

Read more